Tirofiban

CAS No. 144494-65-5

Tirofiban ( L-700462;MK-383;MK-0383 )

Catalog No. M11884 CAS No. 144494-65-5

A potent, selective inhibitor of the platelet fibrinogen receptor GPIIb/IIIa with IC50 of 9 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 47 In Stock
10MG 60 In Stock
25MG 111 In Stock
50MG 195 In Stock
100MG 354 In Stock
500MG 843 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tirofiban
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective inhibitor of the platelet fibrinogen receptor GPIIb/IIIa with IC50 of 9 nM.
  • Description
    A potent, selective inhibitor of the platelet fibrinogen receptor GPIIb/IIIa with IC50 of 9 nM, inhibition of platelet aggregation; displays > 24,000-fold over human umbilical vein endothelial cell fibrinogen receptors; inhibits ex vivo platelet aggregation induced by ADP in anesthetized dogs.Thrombosis Approved
  • Synonyms
    L-700462;MK-383;MK-0383
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    GPIIb/IIIa
  • Research Area
    Cardiovascular Disease
  • Indication
    Thrombosis

Chemical Information

  • CAS Number
    144494-65-5
  • Formula Weight
    440.60
  • Molecular Formula
    C22H36N2O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: < 1 mg/mL
  • SMILES
    O=C(O)[C@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)NS(=O)(CCCC)=O
  • Chemical Name
    L-Tyrosine, N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hartman GD, et al. J Med Chem. 1992 Nov 27;35(24):4640-2.
2. Lynch JJ Jr, et al. J Pharmacol Exp Ther. 1995 Jan;272(1):20-32.
3. Cook NS, et al. Thromb Haemost. 1993 Nov 15;70(5):838-47.
molnova catalog
related products
  • TBC3486

    A potent, selective, non-peptidic integrin α4β1 (VLA-4) antagonist with IC50 of 9 nM.

  • BIO1211

    BIO1211 (BIO-1211) is a potent, highly specific integrin α4β1 (VLA-4) inhibitor with Kd/IC50 of 20 pM/4 nM for the activated form of α4β1.

  • RUC-4

    A potent, selective, non-RGD-mimetic αIIbβ3 integrin receptor antagonist with IC50 of 45 nM, with no activity on αVβ3 receptors.